Therapeutic Potential of Flavonoids in Diabetes Mellitus Management: Molecular Insights and the Future Directions for Drug Design

Diabetes mellitus (DM) is a prevalent metabolic disorder with a rapidly rising global incidence,
presenting a significant burden to healthcare systems worldwide. Flavonoids, a class of naturally
occurring polyphenolic compounds, are well-documented for their diverse pharmacological activities,
particularly their anti-diabetic and anti-inflammatory effects. These secondary metabolites
are commonly found in fruits, vegetables, and fungi and are classified into six main subclasses: flavanols,
flavones, flavanones, isoflavones, anthocyanidins, and chalcones. The interplay between hyperglycemia,
inflammation, and vascular complications in diabetes is now well recognized. Flavonoids
with anti-diabetic properties may help mitigate inflammation by reducing hyperglycemia
through various mechanisms. This review explores the antidiabetic potential and molecular mechanisms
of citrus flavonoids, drawing on updated evidence from in vitro and in vivo studies. Flavonoids
are shown to regulate biomarkers of glycemic control, lipid metabolism, renal function, hepatic enzymes,
and antioxidant defenses. They also modulate signaling pathways implicated in glucose uptake
and insulin sensitivity, which are central to the development of diabetes and its complications.
Furthermore, this review synthesizes current knowledge on the antidiabetic effects of dietary flavonoids,
emphasizing their molecular mechanisms in modulating key pathways such as glucose transporters,
hepatic enzymes, tyrosine kinase inhibitors, AMP-activated protein kinase (AMPK), peroxisome
proliferator-activated receptors (PPARs), and nuclear factor kappa B (NF-κβ). Further research
is essential to deepen our understanding of flavonoids' therapeutic mechanisms in managing diabetes.